Headline News about Ultragenyx Pharmaceu
![](https://cdn.benzinga.com/files/images/story/2023/10/18/image46.jpg?width=1200&height=800&fit=crop)
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2023/october/mmc/mmc-oct18.png?sfvrsn=c9c6a806_2)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 17, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Ultragenyx Pharmaceutical
October 10, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Ultragenyx Pharmaceutical
August 01, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/10/16/mreo.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for Ultragenyx Pharmaceutical
June 06, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/06/apple_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/06/rare.png?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](/next-assets/images/schema-image-default.png)
Ultragenyx Pharmaceutical: Q1 Earnings Insights
May 04, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/ep_us_feature_image_3470.jpeg?width=1200&height=800&fit=crop)
A Preview Of Ultragenyx Pharmaceutical's Earnings
May 03, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Expert Ratings for Ultragenyx Pharmaceutical
April 26, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where Ultragenyx Pharmaceutical Stands With Analysts
February 17, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_111.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Earnings Preview: Ultragenyx Pharmaceutical
February 15, 2023
Via Benzinga
Analyst Expectations for Ultragenyx Pharmaceutical's Future
January 18, 2023
Via Benzinga
The Latest Analyst Ratings for Ultragenyx Pharmaceutical
December 30, 2022
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Analyst Expectations for Ultragenyx Pharmaceutical's Future
December 30, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_29105.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022
November 03, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21043.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6937.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9269.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.